TGFB1 and colonic neoplasm: Recently, Yu et al. [28] showed that MnTE-2-PyP5+ treatment reversed cell phenotypes induced by TGF-β in colon cancer cells and significantly reduced the expression of mesenchymal markers but maintained epithelial marker expression.